Key facts
- Toi Labs’s last known valuation is $30.0M (Jan 2025).
- It has raised $11.0M; the latest was Later Stage VC ($9.0M) in Jan 2025.
- Notable investors include National Institutes of Health, Scale Good Fund, Freestyle Capital, 3Lines, AgeTech Collaborative from AARP — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Toi Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Toi Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Toi Labs
Developer of an AI-powered toilet seat designed to continuously monitor health through biometrics and precision waste data that is used in senior care homes throughout the US. The company's toilet seat monitors output round the clock to provide insights into health and wellness to automate care and help to reduce the risk or impact of certain chronic lower digestive and urinary conditions, enabling seniors and older adults to detect any change in their health condition and take early precautions.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2018
- Employees
- 15
- Website
- toilabs.com/
- Ownership
- Privately Held (backing)
Toi Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Toi Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Toi Labs in its N-PORT filings yet. We sweep new filings monthly.